Minireviews
Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites
Artif Intell Gastroenterol
2(1):1-9.
Published online Feb 28, 2021.
doi: 10.35712/aig.v2.i1.1
Abstract (1125)
|
Core Tip (1451)
|
Full Article (HTML) (3547)
|
Figures (1-2) (504)
|
Tables (1-1) (421)
|
Full Article (PDF)-1383K (387)
|
Audio-354K (3)
|
Peer-Review Report-240K (179)
|
Answering Reviewers-380K (183)
|
Received: 10/15/2020
|
Revised: 12/29/2020
|
Accepted: 02/12/2021
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (12349)
|
Similar Articles (212)
|
Timeline of Article Publication (2)
|
Authors Evaluation (5)
|
Article Quality Tracking (10)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open